Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros










Base de datos
Intervalo de año de publicación
1.
Cell Death Dis ; 10(11): 841, 2019 11 06.
Artículo en Inglés | MEDLINE | ID: mdl-31695025

RESUMEN

The senescence response to oncogenes is believed to be a barrier to oncogenic transformation in premalignant lesions, and describing the mechanisms by which tumor cells evade this response is important for early diagnosis and treatment. The male germ cell-associated protein SSX2 is ectopically expressed in many types of cancer and is functionally involved in regulating chromatin structure and supporting cell proliferation. Similar to many well-characterized oncogenes, SSX2 has the ability to induce senescence in cells. In this study, we performed a functional genetic screen to identify proteins implicated in SSX2-induced senescence and identified several subunits of the Mediator complex, which is central in regulating RNA polymerase-mediated transcription. Further experiments showed that reduced levels of MED1, MED4, and MED14 perturbed the development of senescence in SSX2-expressing cells. In contrast, knockdown of MED1 did not prevent development of B-Raf- and Epirubicin-induced senescence, suggesting that Mediator may be specifically linked to the cellular functions of SSX2 that may lead to development of senescence or be central in a SSX2-specific senescence response. Indeed, immunostaining of melanoma tumors, which often express SSX proteins, exhibited altered levels of MED1 compared to benign nevi. Similarly, RNA-seq analysis suggested that MED1, MED4, and MED14 were downregulated in some tumors, while upregulated in others. In conclusion, our study reveals the Mediator complex as essential for SSX2-induced senescence and suggests that changes in Mediator activity could be instrumental for tumorigenesis.


Asunto(s)
Senescencia Celular/genética , Melanoma/genética , Proteínas de Neoplasias/genética , Proteínas Represoras/genética , Línea Celular Tumoral , Núcleo Celular/genética , Regulación Neoplásica de la Expresión Génica , Humanos , Complejo Mediador/genética , Subunidad 1 del Complejo Mediador/genética , Melanoma/patología , Proteínas Quinasas/genética , Sarcoma Sinovial/genética , Sarcoma Sinovial/patología , Factores de Transcripción/genética , Transcripción Genética , Activación Transcripcional/genética
2.
Nucleic Acids Res ; 47(13): 6668-6684, 2019 07 26.
Artículo en Inglés | MEDLINE | ID: mdl-31114908

RESUMEN

Rearrangement of the 1q12 pericentromeric heterochromatin and subsequent amplification of the 1q arm is commonly associated with cancer development and progression and may result from epigenetic deregulation. In many premalignant and malignant cells, loss of 1q12 satellite DNA methylation causes the deposition of polycomb factors and formation of large polycomb aggregates referred to as polycomb bodies. Here, we show that SSX proteins can destabilize 1q12 pericentromeric heterochromatin in melanoma cells when it is present in the context of polycomb bodies. We found that SSX proteins deplete polycomb bodies and promote the unfolding and derepression of 1q12 heterochromatin during replication. This further leads to segregation abnormalities during anaphase and generation of micronuclei. The structural rearrangement of 1q12 pericentromeric heterochromatin triggered by SSX2 is associated with loss of polycomb factors, but is not mediated by diminished polycomb repression. Instead, our studies suggest a direct effect of SSX proteins facilitated though a DNA/chromatin binding, zinc finger-like domain and a KRAB-like domain that may recruit chromatin modifiers or activate satellite transcription. Our results demonstrate a novel mechanism for generation of 1q12-associated genomic instability in cancer cells.


Asunto(s)
Ensamble y Desensamble de Cromatina , Cromosomas Humanos Par 1/metabolismo , Heterocromatina/metabolismo , Proteínas de Neoplasias/fisiología , Proteínas Represoras/fisiología , Empalme Alternativo , Línea Celular Tumoral , ADN de Neoplasias/genética , ADN Satélite/genética , Represión Epigenética , Regulación Neoplásica de la Expresión Génica , Técnicas de Silenciamiento del Gen , Inestabilidad Genómica , Humanos , Melanoma/patología , Proteínas de Neoplasias/genética , Mutación Puntual , Complejo Represivo Polycomb 1/antagonistas & inhibidores , Complejo Represivo Polycomb 1/genética , Dominios Proteicos , Pliegue de Proteína , ARN Interferente Pequeño/genética , Proteínas Recombinantes/metabolismo , Proteínas Represoras/genética , Eliminación de Secuencia , Transcripción Genética , Dedos de Zinc/fisiología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA